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Background: Helicobacter cinaedi causes bacteremia without characteristic clinical symptoms and is firstly isolated
from human immunodeficiency virus (HIV)-positive homosexual men.
Findings: Here we describe, for the first time case report, two female patients with diabetes who had H. cinaedi
bacteremia. Some cases of H. cinaedi bacteremia may require long-term administration of multiple antibiotics prior
to the resolution of infection.
Conclusions: Therefore, these cases indicate that it is important to consider H. cinaedi in patients with diabetes
presenting with bacteremia, especially in patients with poor glycemic control.
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Helicobacter cinaedi is a Gram-negative enterohepatic
bacterium of the Helicobacteraceae family that was first
identified in 1985 among immunocompromised Euro-
pean and American men with human immunodeficiency
virus (HIV) infections (Totten et al. 1985). In Japan, the
isolation of H. cinaedi from blood culture was first re-
ported in 2003 (Murakami et al. 2003), and it has since
been occasionally isolated from samples obtained from
patients with bacteremia and sepsis. In this report, we
describe our experience with two patients with diabetes
who had H. cinaedi bacteremia; in addition, we include a
literature review.
Case reports
Case 1: A 76-year-old female with a history of slowly
progressive type 1 diabetes, treated for 30 years. She was
being treated for rheumatoid arthritis (oral prednisolone,
5 mg/day, and had poor glycemic control specified by a
glycated hemoglobin (HbA1c) level of 7.8% while on a
regimen of 50% insulin lispro protamine suspension and
50% insulin lispro injection (HUMALOG® Mix50/50TM;* Correspondence: minoru.takemoto@faculty.chiba-u.jp
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the evening, as well as miglitol (10 mg/day) and mitigli-
nide (450 mg/day). She presented to the emergency unit
of our hospital with a fever of 39°C, headache, erythema
on the trunk, and joint pain. On admission, her body
temperature was 40.2°C, pulse rate 134 beats/min, blood
pressure 150/70 mmHg, height 145 cm, and body weight
38 kg. Routine laboratory testing showed an elevated
leukocyte count of 11.8 × 103 cells/μL and a C-reactive
protein level of 19.21 mg/dL. Serological tests for syph-
ilis and HIV were negative. As a result, we suspected a
bacterial infection, especially because of the significant
inflammation reaction in blood sampling; therefore, we
decided to begin empiric cefepime therapy at 2 g/day.
During hospitalization, our patient complained of a de-
creased appetite; thus, we commenced blood glucose
monitoring on a sliding scale to maintain her prepran-
dial blood glucose level at approximately 120 mg/dL. On
day 2 of admission, her fever declined and erythema im-
proved. On day 4, she was discharged after a change to
oral cefotiam at 1800 mg/day. On day 9, she again devel-
oped high fever, poor appetite, and fatigue, and on day
10, she was readmitted to our hospital. On the same
day, H. cinaedi was detected from a blood culture taken
on the first day of admission; we accordingly started ad-
ministering minocycline at 200 mg/day. A blood culture
taken on the second day of re-admission was positive for
H. cinaedi, indicating persistent bacteremia. However,an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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cycline (200 mg/day) was continued. On day 18 after the
initial admission, the third blood culture was taken, then
she was discharged a second time. Later, we confirmed
that her third blood culture was negative in an out-
patient clinic and prescribed completion of the antibiotic
regimen.
Case 2: A 47-year-old female diagnosed with type 2
diabetes 2 years before, and treatment started immedi-
ately thereafter. However, after a year, she stopped taking
medications on her own decision. She presented to
emergency department of our hospital with a fever of
38°C and bilateral lower leg pain for three days. She was
hospitalized with a diagnosis of lower right leg cellulitis,
and we began cefazolin administration at 3 g/day. On
admission, her diabetic control was poor (HbA1c, 11.5%,
postprandial blood glucose, 268 mg/dL); in addition, her
body temperature was 39.2°C, pulse rate 106 beats/min,
blood pressure 137/71 mmHg, height 166 cm, and body
weight 61 kg. Routine laboratory testing showed an ele-
vated leukocyte count of 13.8 × 103 cells/μL and a C-
reactive protein level of 4.49 mg/dL. Serological tests for
syphilis and HIV were negative. Soon after starting anti-
biotic treatment, her fever subsided. Five days later, red-
ness and swelling disappeared; therefore, we changed
treatment to cefdinir at 900 mg/day. She was discharged
on day 8. The following day, we confirmed H. cinaedi
from the blood culture taken on day 1; nevertheless, we
decided to adopt a wait-and-see approach because no
exacerbation of disease was observed since her initial
admission.
Discussion
H. cinaedi is a rare infection primarily detected among
HIV-positive patients in western countries. In Japan, most
patients with H. cinaedi infection were HIV-negative, but
immunocompromised (Araoka et al. 2014). H. cinaedi set-
tles in the digestive tracts of humans, monkeys, dogs, and
cats. Some cases of hospital-acquired outbreaks have also
been reported (Rimbara et al. 2012). Neither of our pa-
tients had contact with animals, and because they came
from different villages, they had no previous contact each
other. Hence, the routes of infection remain unknown.
Case 1 was prescribed 5 mg of prednisolone per day for
rheumatoid arthritis, and both patients had poorly con-
trolled diabetes. It has been reported that migratory, anti-
infection, and phagocytic functions of leukocytes are
compromised in patients with diabetes especially by high
glucose levels. Therefore, patients with poorly controlled
diabetes might be at a higher risk for H. cinaedi infection.
However, there is no consensus on characteristic clinical
symptoms of H. cinaedi infection and H. cinaedi is a fas-
tidious organism, thereby making it difficult to clinically
diagnosis.The average separation and processing period of a
blood culture to detect H. cinaedi is 5 days (Araoka et al.
2014), and the frequency of positive blood culture sam-
ples is reported to be 0.22% (Araoka et al. 2014). The ac-
tual frequency is probably higher because culturing this
organism is difficult. Other reports have advocated
genetic analyses, such as 16S-rRNA sequence and
PCR-restriction fragment length polymorphism analyses
(Oyama et al. 2012), for definitive diagnosis, although
these methods are not feasible for routine laboratory
analysis due to imbalance in cost–benefit ratio to detect
very rare organisms. No guidelines have been provided
for the treatment of H. cinaedi infections, even though
this organism is reportedly sensitive to many antibiotics.
In general, cephalosporins, carbapenems, tetracyclines,
and aminoglycosides were found to be effective; how-
ever, various H. cinaedi isolates in Japan have shown
increased resistance to penicillins and resistance to
macrolides and quinolones (Kawamura et al. 2014).
Therefore, some cases of H. cinaedi bacteremia may re-
quire long-term administration of multiple antibiotics
prior to the resolution of infection.
In conclusion, two patients with poorly controlled dia-
betes presented with H. cinaedi bacteremia. Because H.
cinaedi develops no characteristic clinical symptoms, it
is important to consider H. cinaedi infection, especially
in patients with poorly controlled diabetes who experi-
ence a relapse of infection after curative antibiotic
treatment.Consent
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